NCT06636045
Blood Flow Restriction Following ACLR w/Quad Autograft
Enrolling by Invitation
Not specifiedAges 14–40ObservationalUniversity of Kansas Medical CenterInvestigator-initiated
~40 participants
Updated 2025-04-06 on ClinicalTrials.gov
What's tested:Not applicable- observational study
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quad muscle Strength
Measured over At 6 week post surgical timepoints
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesKansas1
Study leadership
- Matthew Vopat, MD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patient undergoing anterior cruciate ligament construction utilizing a quadriceps autograft
Age 14 - 40 years old
Exclusion
Comorbid conditions (i.e.: hypertension, diabetes, obesity, etc.)
Patient taking blood thinners or at risk of embolism
Revision anterior cruciate ligament construction
Allograft based reconstruction
Non-quadriceps graft
What this trial measures
- Quad muscle StrengthAt 6 week post surgical timepoints
Compare the muscle strength gain or loss between BFR group and control group
- Return to sport6 week intervals
Compare the time it takes participants to return to sport in BFR group to control group